MARC details
| 000 -LEADER |
| fixed length control field |
08156cam a2200937 i 4500 |
| 001 - CONTROL NUMBER |
| control field |
ocn995850704 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20250702170809.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr nn||||mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
170731s2017 nyua ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
RML |
| Language of cataloging |
eng |
| Description conventions |
pn |
| Transcribing agency |
RML |
| Modifying agency |
RML |
| -- |
OCLCO |
| -- |
GW5XE |
| -- |
SCB |
| -- |
YDX |
| -- |
UAB |
| -- |
OCLCO |
| -- |
OCLCF |
| -- |
STF |
| -- |
AZU |
| -- |
COO |
| -- |
OCLCO |
| -- |
TFH |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
BUF |
| -- |
OCLCO |
| -- |
CAUOI |
| -- |
OCLCO |
| -- |
VT2 |
| -- |
UWO |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
MERER |
| -- |
OCLCQ |
| -- |
U3W |
| -- |
UKMGB |
| -- |
OCLCA |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCA |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
WSU |
| -- |
OCLCL |
| -- |
OCLCQ |
| -- |
UKAHL |
| -- |
EBLCP |
| -- |
OCLCO |
| -- |
OCLCQ |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
| National bibliography number |
GBB8M4913 |
| Source |
bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
| Record control number |
101717472 |
| Source |
DNLM |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
| Record control number |
019140456 |
| Source |
Uk |
| 019 ## - |
| -- |
999589244 |
| -- |
1005003893 |
| -- |
1021278560 |
| -- |
1048127083 |
| -- |
1079338533 |
| -- |
1081224281 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781493971725 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1493971727 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
9781493971701 |
| Qualifying information |
(print) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
1493971700 |
| 024 7# - OTHER STANDARD IDENTIFIER |
| Standard number or code |
10.1007/978-1-4939-7172-5 |
| Source of number or code |
doi |
| 029 1# - (OCLC) |
| OCLC library identifier |
AU@ |
| System control number |
000061156516 |
| 029 1# - (OCLC) |
| OCLC library identifier |
UKMGB |
| System control number |
019140456 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)995850704 |
| Canceled/invalid control number |
(OCoLC)999589244 |
| -- |
(OCoLC)1005003893 |
| -- |
(OCoLC)1021278560 |
| -- |
(OCoLC)1048127083 |
| -- |
(OCoLC)1079338533 |
| -- |
(OCoLC)1081224281 |
| 037 ## - SOURCE OF ACQUISITION |
| Stock number |
com.springer.onix.9781493971725 |
| Source of stock number/acquisition |
Springer Nature |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RA1238 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
W1 |
| Item number |
ME9616J v.1641 2017 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
QV 771 |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MMG |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MED071000 |
| Source |
bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
615.7/04 |
| Edition number |
23 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
| Title |
Drug safety evaluation : |
| Remainder of title |
methods and protocols / |
| Statement of responsibility, etc. |
Jean-Charles Gautier. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
Second edition |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Humana Press : |
| -- |
Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
©2017. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource (xi, 427 pages) : |
| Other physical details |
illustrations (some color) |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 490 1# - SERIES STATEMENT |
| Series statement |
Methods in molecular biology, |
| International Standard Serial Number |
1940-6029 ; |
| Volume/sequential designation |
volume no. 1641 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Title |
Nonclinical development of combination drugs / |
| Statement of responsibility |
Alberto Lodola -- |
| Title |
Juvenile nonclinical safety studies in support of pediatric drug development / |
| Statement of responsibility |
Paul C. Barrow and Georg Schmitt -- |
| Title |
Procedures of necropsy and tissue sampling / |
| Statement of responsibility |
Laurence Fiette, Mohamed Slaoui, and Anne-Laure Bauchet -- |
| Title |
Tissue sampling and processing for histopathology evaluation / |
| Statement of responsibility |
Mohamed Slaoui, Anne-Laure Bauchet, and Laurence Fiette -- |
| Title |
Principles and methods of immunohistochemistry / |
| Statement of responsibility |
José A. Ramos-Vara -- |
| Title |
Applications of mass spectrometry imaging for safety evaluation / |
| Statement of responsibility |
David Bonnel and Jonathan Stauber Part III Genetic Toxicology -- |
| Title |
In vivo rat T-lymphocyte Pig-a assay : detection and expansion of cells deficient in the GPI-anchored CD48 surface marker for analysis of mutation in the endogenous Pig-a gene / |
| Statement of responsibility |
Vasily N. Dobrovolsky, Javier Revollo, Dayton M. Petibone, and Robert H. Heflich -- |
| Title |
Detection of in vivo mutation in the Pig-a gene of mouse bone marrow erythroids / |
| Statement of responsibility |
Takafumi Kimoto and Daishiro Miura -- |
| Title |
Use of bacterial repair endonucleases in the comet assay / |
| Statement of responsibility |
Andrew R. Collins -- |
| Title |
Automated patch-clamp methods for the hERG cardiac potassium channel / |
| Statement of responsibility |
Sylvie Houtmann, Brigitte Schombert, Camille Sanson, Michel Partiseti, and G. Andrees Bohme -- |
| Title |
Impedance measurement in induced pluripotent stem cell-derived cardiomyocytes / |
| Statement of responsibility |
Emma-Jane Poulton -- |
| Title |
Target safety assessment : strategies and resources / |
| Statement of responsibility |
Richard J. Brennan -- |
| Title |
NMR and MS methods for metabolomics / |
| Statement of responsibility |
Alexander Amberg, Björn Riefke, Götz Schlotterbeck, Alfred Ross, Hans Senn, Frank Dieterle, and Matthias Keck -- |
| Title |
Protocols and applications of cellular metabolomics in safety studies using precision-cut tissue slices and carbon 13 NMR / |
| Statement of responsibility |
Gabriel Baverel, Maha El Hage, and Guy Martin -- |
| Title |
Statistical analysis of auantitative RT-PCR results / |
| Statement of responsibility |
Richard Khan-Malek and Ying Wang -- |
| Title |
Evaluation of mitochondrial respiration in cultured rat hepatocytes / |
| Statement of responsibility |
Jean-Pierre Marchandeau and Gilles Labbe -- |
| Title |
FETAX assay for evaluation of developmental toxicity / |
| Statement of responsibility |
Isabelle Mouche, Laure Malésic, and Olivier Gillardeaux -- |
| Title |
Evaluation of embryotoxicity using the Zebrafish model / |
| Statement of responsibility |
Lisa Truong and Robert L. Tanguay -- |
| Title |
Absolute quantification of toxicological biomarkers via mass spectrometry / |
| Statement of responsibility |
Thomas Y.K. Lau, Ben C. Collins, Peter Stone, Ning Tang, William M. Gallagher, and Stephen R. Pennington -- |
| Title |
Next-generation sequencing to investigate urinary microRNAs from Macaca fascicularis (cynomolgus monkey) / |
| Statement of responsibility |
Yaligara Veeranagouda, Jean-François Léonard, Jean-Charles Gautier, and Eric Boitier -- |
| Title |
Quantitative RT-PCR for microRNAs in biofluids / |
| Statement of responsibility |
Michael Thorsen, Thorarinn Blondal, and Peter Mouritzen -- |
| Title |
Chromogenic in situ hybridization methods for microRNA biomarker monitoring of drug safety and efficacy / |
| Statement of responsibility |
Barbara R. Gould, Tina Damgaard, and Boye Schnack Nielsen -- |
| Title |
Urine exosome isolation and characterization / |
| Statement of responsibility |
Jonathan M. Street, Erik H. Koritzinsky, Deonna M. Glispie, and Peter S.T. Yuen. |
| 588 0# - SOURCE OF DESCRIPTION NOTE |
| Source of description note |
Online resource; title from PDF title page (SpringerLink, viewed July 31, 2017). |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
This second edition provides up-to-date chapters and new chapters focusing on the most recent advances in the field of drug safety evaluation. Divided into seven parts, chapters detail specific aspects related to the experimental design of preclinical studies conducted to support the safety of pediatric and combination drugs, necropsy and histopathology evaluation, mass spectrometry imaging, genetic toxicology protocols including the Pig-a mutation assay, safety pharmacology methods such as automatization of patch-clamp procedures, target safety assessment for investigative toxicology, screening assays for developmental toxicology, and methods to characterize novel translational safety biomarkers like microRNAs. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting to avoid known pitfalls. Authoritative and practical, Drug Safety Evaluation: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Toxicology. |
| 9 (RLIN) |
86066 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Testing. |
| 9 (RLIN) |
82056 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Poisoning. |
| 9 (RLIN) |
86892 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Side effects. |
| 9 (RLIN) |
107113 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Evaluation Studies as Topic |
| 9 (RLIN) |
30855 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Poisoning |
| 9 (RLIN) |
86892 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Investigative Techniques |
| Authority record control number |
(DNLM)D008919 |
| 9 (RLIN) |
12500 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug Discovery |
| General subdivision |
methods |
| 9 (RLIN) |
86383 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Substance-Related Disorders |
| 9 (RLIN) |
4914 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug Evaluation, Preclinical |
| General subdivision |
methods |
| 9 (RLIN) |
80630 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug-Related Side Effects and Adverse Reactions |
| 9 (RLIN) |
86893 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Toxicity Tests |
| 9 (RLIN) |
80294 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Médicaments |
| General subdivision |
Toxicologie. |
| 9 (RLIN) |
114984 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Médicaments |
| General subdivision |
Essais cliniques. |
| 9 (RLIN) |
105682 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Intoxication. |
| 9 (RLIN) |
107046 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Toxicomanie. |
| 9 (RLIN) |
186828 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Médicaments |
| General subdivision |
Effets secondaires. |
| 9 (RLIN) |
970528 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmacology. |
| Source of heading or term |
bicssc |
| 9 (RLIN) |
5990 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Medical |
| General subdivision |
Pharmacology. |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
80262 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Testing |
| Source of heading or term |
fast |
| 9 (RLIN) |
82056 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Toxicology |
| Source of heading or term |
fast |
| 9 (RLIN) |
86066 |
| 655 #0 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Electronic books. |
| 9 (RLIN) |
396 |
| 655 #2 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Laboratory Manual |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Laboratory manuals |
| Source of term |
fast |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Laboratory manuals. |
| Source of term |
lcgft |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Manuels de laboratoire. |
| Source of term |
rvmgf |
| 9 (RLIN) |
966128 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Gautier, Jean-Charles, |
| Relator term |
editor. |
| 9 (RLIN) |
86894 |
| 758 ## - |
| -- |
has work: |
| -- |
Drug safety evaluation (Text) |
| -- |
https://id.oclc.org/worldcat/entity/E39PCFtfBh8WhFrFhBw7XBDFyq |
| -- |
https://id.oclc.org/worldcat/ontology/hasWork |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
| Relationship information |
Print version: |
| Title |
Drug safety evaluation. |
| International Standard Book Number |
9781493971701 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Methods in molecular biology (Clifton, N.J.) ; |
| Volume number/sequential designation |
v. 1641. |
| International Standard Serial Number |
1064-3745 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
<a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-4939-7172-5">https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-4939-7172-5</a> |
| 938 ## - |
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL31097764 |
| 938 ## - |
| -- |
Askews and Holts Library Services |
| -- |
ASKH |
| -- |
AH35661734 |
| 938 ## - |
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
14735180 |
| 994 ## - |
| -- |
92 |
| -- |
ATIST |